====== NFN1 0.1μM R01 exp49 ====== ==== Mechanism of Action ==== Nitrofuran derivative, candidate ALDH2 inhibitor * **Class / Subclass 1:** Infectious Disease / Antibiotic ==== Technical Notes ==== * **PubChem Name:** %%Ethyl 5-ethyl-2-[(5-nitrofuran-2-carbonyl)amino]thiophene-3-carboxylate%% * **Synonyms:** N/A * **CAS #:** 219620-36-7 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/2799305|2799305]] * **IUPAC:** %%ethyl 5-ethyl-2-[(5-nitrofuran-2-carbonyl)amino]thiophene-3-carboxylate%% * **INCHI Name:** InChI=1S/C14H14N2O6S/c1-3-8-7-9(14(18)21-4-2)13(23-8)15-12(17)10-5-6-11(22-10)16(19)20/h5-7H,3-4H2,1-2H3,(H,15,17) * **INCHI Key:** OASNGLRREXBINI-UHFFFAOYSA-N * **Molecular Weight:** 338.34 * **Canonical SMILES:** CCC1=CC(=C(S1)NC(=O)C2=CC=C(O2)[N+](=O)[O-])C(=O)OCC * **Isomeric SMILES:** N/A * **Molecular Formula:** C14H14N2O6S {{:chemogenomics:structures:chem-0029.svg?nolink}} * **Supplier Name:** Maybridge * **Catalog #:** BTB05727SC * **Lot #:** N/A * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C14H14N2O6S 339.06453; found 339.0634 * **Platform ID:** NFN1 * **Min:** -1.7682; **Max:** 66.1639 {{:chemogenomics:dose_response:dr_100.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |0.3734 | | IC30 |1.2393 | | IC40 |3.3135 | | IC50 |8.1701 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 01 * **Dose**: 100nM * **Days of incubation**: 8 * **Doublings**: 6.7 * **Numbers of reads**: 12398986 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |0/0|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/NFN1_0.1uM_Round-1_exp49.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp49.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:N:NSMCE1|NSMCE1]]|-3.03|0.14| |[[:human_genes:V:VEZT|VEZT]]|-2.70|0.12| |[[:human_genes:U:UBA3|UBA3]]|-2.52|0.71| |[[:human_genes:G:GOLT1B|GOLT1B]]|-2.48|0.14| |[[:human_genes:P:PAFAH1B2|PAFAH1B2]]|-2.47|0.35| |[[:human_genes:Z:ZCRB1|ZCRB1]]|-2.44|0.35| |[[:human_genes:G:GMPPB|GMPPB]]|-2.44|0.54| |[[:human_genes:E:ERCC2|ERCC2]]|-2.43|0.54| |[[:human_genes:C:CXorf67|CXorf67]]|-2.42|0.35| |[[:human_genes:T:TTC37|TTC37]]|-2.41|0.68| |[[:human_genes:N:NFU1|NFU1]]|-2.35|0.35| |[[:human_genes:S:SERPINI2|SERPINI2]]|-2.27|0.35| |[[:human_genes:E:ETV5|ETV5]]|-2.26|0.54| |[[:human_genes:A:ATRX|ATRX]]|-2.23|0.71| |[[:human_genes:C:C1orf131|C1orf131]]|-2.20|0.71| |[[:human_genes:S:SRP14|SRP14]]|-2.20|0.35| |[[:human_genes:D:DBR1|DBR1]]|-2.19|0.68| |[[:human_genes:G:GKAP1|GKAP1]]|-2.17|0.76| |[[:human_genes:D:DAAM1|DAAM1]]|-2.16|0.71| |[[:human_genes:N:NRDE2|NRDE2]]|-2.16|0.77| |[[:human_genes:E:ENOPH1|ENOPH1]]|-2.15|0.71| |[[:human_genes:S:SLC30A4|SLC30A4]]|-2.13|0.54| |[[:human_genes:L:LPXN|LPXN]]|-2.10|0.71| |[[:human_genes:F:FNDC9|FNDC9]]|-2.10|0.71| |[[:human_genes:E:ETV7|ETV7]]|-2.09|0.68| |[[:human_genes:R:RBX1|RBX1]]|-2.07|0.71| |[[:human_genes:M:MSH3|MSH3]]|-2.06|0.71| |[[:human_genes:Z:ZNF711|ZNF711]]|-2.06|0.71| |[[:human_genes:K:KIF2A|KIF2A]]|-2.05|0.68| |[[:human_genes:K:KCTD5|KCTD5]]|-2.05|0.71| |[[:human_genes:P:PLEKHB1|PLEKHB1]]|2.12|0.69| |[[:human_genes:R:RRP15|RRP15]]|2.12|0.69| |[[:human_genes:N:NUP155|NUP155]]|2.12|0.69| |[[:human_genes:F:FAM160A1|FAM160A1]]|2.15|0.69| |[[:human_genes:C:CHGA|CHGA]]|2.15|0.69| |[[:human_genes:M:MCF2L|MCF2L]]|2.15|0.69| |[[:human_genes:P:PDS5B|PDS5B]]|2.16|0.69| |[[:human_genes:P:PSMD3|PSMD3]]|2.17|0.69| |[[:human_genes:M:MYO7B|MYO7B]]|2.19|0.48| |[[:human_genes:Z:ZC3H4|ZC3H4]]|2.19|0.69| |[[:human_genes:F:FRZB|FRZB]]|2.19|0.48| |[[:human_genes:P:PUM1|PUM1]]|2.20|0.48| |[[:human_genes:R:RUFY3|RUFY3]]|2.24|0.69| |[[:human_genes:U:UBE2Q2L|UBE2Q2L]]|2.24|0.70| |[[:human_genes:A:ALMS1|ALMS1]]|2.24|0.69| |[[:human_genes:C:CCNA2|CCNA2]]|2.25|0.69| |[[:human_genes:T:TRIM34|TRIM34]]|2.31|0.48| |[[:human_genes:B:BRI3BP|BRI3BP]]|2.35|0.48| |[[:human_genes:I:IER3IP1|IER3IP1]]|2.36|0.69| |[[:human_genes:P:PI3|PI3]]|2.36|0.47| |[[:human_genes:P:PSMA6|PSMA6]]|2.37|0.67| |[[:human_genes:I:IGFN1|IGFN1]]|2.37|0.48| |[[:human_genes:P:PSMD14|PSMD14]]|2.37|0.69| |[[:human_genes:Z:ZNF219|ZNF219]]|2.39|0.48| |[[:human_genes:M:MFI2|MFI2]]|2.45|0.56| |[[:human_genes:P:PHYH|PHYH]]|2.48|0.48| |[[:human_genes:P:POLA2|POLA2]]|2.55|0.67| |[[:human_genes:M:MARVELD1|MARVELD1]]|2.58|0.69| |[[:human_genes:Z:ZNF276|ZNF276]]|2.72|0.48| |[[:human_genes:N:NOP2|NOP2]]|3.19|0.47| ^Screen^Correlation^Plot^ |[[:results:exp61|YM155 0.0002μM R01 exp61]]|0.063|| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|0.063|| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|0.062|| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|0.06|| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|0.054|| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|0.085|| |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|0.07|| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|0.054|| {{:chemogenomics:comparison_plots:exp49_vs_exp61.png?nolink |}} {{:chemogenomics:comparison_plots:exp49_vs_exp51.png?nolink |}} {{:chemogenomics:comparison_plots:exp49_vs_exp58.png?nolink |}} {{:chemogenomics:comparison_plots:exp49_vs_exp54.png?nolink |}} {{:chemogenomics:comparison_plots:exp49_vs_exp53.png?nolink |}} {{:chemogenomics:comparison_plots:exp40_vs_exp49.png?nolink |}} {{:chemogenomics:comparison_plots:exp41_vs_exp49.png?nolink |}} {{:chemogenomics:comparison_plots:exp47_vs_exp49.png?nolink |}} No GO term hits below threshold. (FDR <0.05) No GO term hits below threshold. (FDR <0.05)